Stock Comparison
LLY vs SNY
Eli Lilly and Company and Sanofi ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$1.08T
$102.81B
P/E (TTM)
42.9
19.1
Forward P/E
31.1
8.8
Price/Sales
14.9
2.2
Price/Book
32.2
1.2
EV/EBITDA
28.8
12.2
Dividend Yield
0.55%
0.00%
Profitability
Net Margin
35.00%
16.00%
Operating Margin
49.40%
20.00%
Return on Equity
107.50%
6.58%
Return on Assets
20.70%
4.67%
Growth (YoY)
Revenue Growth
55.50%
6.00%
Earnings Growth
169.90%
-11.70%
Price & Risk
Beta
0.5
0.3
52-Week High
$1,215.76
$49.91
52-Week Low
$619.40
$40.89
Analyst Target
$1,222.62
$55.90
Compare LLY and SNY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.